1. Home
  2. REVB vs BNBX Comparison

REVB vs BNBX Comparison

Compare REVB & BNBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revelation Biosciences Inc.

REVB

Revelation Biosciences Inc.

HOLD

Current Price

$0.63

Market Cap

5.1M

Sector

Health Care

ML Signal

HOLD

Logo Applied DNA Sciences Inc.

BNBX

Applied DNA Sciences Inc.

N/A

Current Price

$1.59

Market Cap

5.5M

ML Signal

N/A

Company Overview

Basic Information
Metric
REVB
BNBX
Founded
2020
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Other Consumer Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
5.1M
5.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
REVB
BNBX
Price
$0.63
$1.59
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
5.3M
277.8K
Earning Date
03-05-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,136,935.00
Revenue This Year
N/A
$253.12
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.11
52 Week Low
$0.60
$1.16
52 Week High
$17.04
$157.50

Technical Indicators

Market Signals
Indicator
REVB
BNBX
Relative Strength Index (RSI) 30.42 N/A
Support Level $0.71 N/A
Resistance Level $0.96 N/A
Average True Range (ATR) 0.14 0.00
MACD -0.01 0.00
Stochastic Oscillator 4.73 0.00

Price Performance

Historical Comparison
REVB
BNBX

About REVB Revelation Biosciences Inc.

Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).

About BNBX Applied DNA Sciences Inc.

Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.

Share on Social Networks: